Replies to post #67918 on NanoViricides Inc. (NNVC)

[JG36]

I'm sorry Puffer, if you are incapable of understanding the nuances of debate. Speaking about the ability of start up biotechs generally to raise large sums of money by diluting their shares and pointing out that NNVC could also raise money by diluting its shares (but not specifying any share count for NNVC) does not mean that I said that NNVC had to triple its share count to pay for phase III trials.